InvestorsHub Logo
Followers 96
Posts 4859
Boards Moderated 0
Alias Born 02/07/2021

Re: ilovetech post# 538333

Thursday, 11/24/2022 11:14:06 AM

Thursday, November 24, 2022 11:14:06 AM

Post# of 716104
It takes 1-2B to bring a treatment to market. BP are certainly glad they didn't have to dilute their own shareholders to create DCVax as well as the manufacturing process to make the vaccine viable as a treatment. Typically R&D expenses are sunk costs though I believe management will price DCVax accordingly to recover these past expenses. In any partnership or buyout they will be recovered as the annual revenue brought in on rGBM and nGBM will be much higher than 1-2B once manufacturing are able to ramp up production.

Do your own research. I am not providing legal or investment advice. This is an anonymous forum for entertainment purposes only. Don't trust anything you read.

Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent NWBO News